Holdings
Fidelity Disruptive Medicine ETF
As of May 31, 2026, Fidelity Disruptive Medicine ETF reported 66 positions worth US$39.7M. Largest: Ucb S.a., Lifestance Health Group, Inc. and Danaher Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Ucb S.a. | 6,605 | US$1.94M | −1,694 | May 31, 2026 |
| Lifestance Health Group, Inc. | 227K | US$1.75M | +20,308 | May 31, 2026 |
| Danaher Corporation | 7,675 | US$1.4M | −4,605 | May 31, 2026 |
| 10x Genomics, Inc. | 45,000 | US$1.27M | no change | May 31, 2026 |
| Intuitive Surgical, Inc. | 2,816 | US$1.2M | −984 | May 31, 2026 |
| Cogent Biosciences, Inc. | 33,428 | US$1.17M | −26,572 | May 31, 2026 |
| Alnylam Pharmaceuticals, Inc. | 3,791 | US$1.14M | −2,269 | May 31, 2026 |
| Argenx Se | 1,365 | US$1.14M | −1,688 | May 31, 2026 |
| Unitedhealth Group Incorporated | 2,424 | US$922K | −549 | May 31, 2026 |
| Bio-techne Corp | 17,786 | US$919K | +9,427 | May 31, 2026 |